These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19811301)

  • 21. Cell damage and autoimmunity: a critical appraisal.
    Mackay IR; Leskovsek NV; Rose NR
    J Autoimmun; 2008; 30(1-2):5-11. PubMed ID: 18194728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [DNA-hydrolyzing antibodies in lymphoproliferative disorders].
    Kozyr' AV; Kolesnikov AV; Iakhnina EI; Astsaturov IA; Varlamova EIu; Kirillov EV; Gabibov AG
    Biull Eksp Biol Med; 1996 Feb; 121(2):204-6. PubMed ID: 9026132
    [No Abstract]   [Full Text] [Related]  

  • 23. DNA-hydrolyzing autoantibodies in autoimmune pathologies.
    Schourov DV; Gololobov GV; Makarevich OI; Yadav RP; Chernova EA; Nevinsky GA; Prokaeva TB; Alekberova ZS; Gabibov AG
    Ann N Y Acad Sci; 1995 Mar; 750():255-64. PubMed ID: 7785851
    [No Abstract]   [Full Text] [Related]  

  • 24. Nucleosome autoantibodies.
    Decker P
    Clin Chim Acta; 2006 Apr; 366(1-2):48-60. PubMed ID: 16364274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formation of different abzymes in autoimmune-prone MRL-lpr/lpr mice is associated with changes in colony formation of haematopoietic progenitors.
    Andryushkova AA; Kuznetsova IA; Bineva VN; Toporkova LB; Sakhno LV; Tikhonova MA; Chernykh ER; Orlovskaya IA; Nevinsky GA
    J Cell Mol Med; 2007; 11(3):531-51. PubMed ID: 17635644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dephosphorylation of autoantigenic ribosomal P proteins during Fas-L induced apoptosis: a possible trigger for the development of the autoimmune response in patients with systemic lupus erythematosus.
    Zampieri S; Degen W; Ghiradello A; Doria A; van Venrooij WJ
    Ann Rheum Dis; 2001 Jan; 60(1):72-6. PubMed ID: 11114288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of autoantigens in the driving of autoimmune diseases.
    Roitt IM
    Immunol Ser; 1993; 59():119-29. PubMed ID: 7681695
    [No Abstract]   [Full Text] [Related]  

  • 28. Autoantibodies against protective molecules--C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus.
    Shoenfeld Y; Szyper-Kravitz M; Witte T; Doria A; Tsutsumi A; Tatsuya A; Dayer JM; Roux-Lombard P; Fontao L; Kallenberg CG; Bijl M; Matthias T; Fraser A; Zandman-Goddard G; Blank M; Gilburd B; Meroni PL
    Ann N Y Acad Sci; 2007 Jun; 1108():227-39. PubMed ID: 17899624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular DNA and autoimmune diseases.
    Lou H; Pickering MC
    Cell Mol Immunol; 2018 Aug; 15(8):746-755. PubMed ID: 29553134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiopathology of natural auto-antibodies: the case for regulation.
    Zelenay S; Moraes Fontes MF; Fesel C; Demengeot J; Coutinho A
    J Autoimmun; 2007 Dec; 29(4):229-35. PubMed ID: 17967665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA-protein complexes. Natural targets for DNA-hydrolyzing antibodies.
    Gololobov GV; Mikhalap SV; Starov AV; Kolesnikov AF; Gabibov AG
    Appl Biochem Biotechnol; 1994; 47(2-3):305-14; discussion 314-5. PubMed ID: 7944345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Introduction to medical abzymology: the present and the prospect].
    Suchkov SV; Gabibov AG
    Vestn Ross Akad Med Nauk; 2005; (10):44-53. PubMed ID: 16320706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Origin and structure of autoantibodies and antigens in autoimmune rheumatic diseases.
    Rahman A; Stollar BD
    Lupus; 2008 Mar; 17(3):232-5. PubMed ID: 18372367
    [No Abstract]   [Full Text] [Related]  

  • 34. Altered structure of autoantigens during apoptosis.
    Hall JC; Casciola-Rosen L; Rosen A
    Rheum Dis Clin North Am; 2004 Aug; 30(3):455-71, vii. PubMed ID: 15261336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does the cellular localization of antigens in or on apoptotic blebs influence the pathogenicity or benefit of cognate antibodies? Comment on the article by Dieudé et al.
    Clancy RM; Chan EK; Chandrashekhar S; Buyon JP
    Arthritis Rheum; 2003 Jul; 48(7):2080-2; author reply 2082-3. PubMed ID: 12847710
    [No Abstract]   [Full Text] [Related]  

  • 36. Anti-pentraxin antibodies in autoimmune systemic diseases: Focus on anti-pentraxin-3 autoantibodies.
    Augusto JF; Poli C; Beauvillain C; Subra JF; Jaillon S; Renier G; Chevailler A; Puéchal X; Delneste Y; Jeannin P
    Int Rev Immunol; 2017 May; 36(3):145-153. PubMed ID: 28471269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eighth international workshop on autoantibodies and autoimmunity Berlin, Germany, 10-13 September, 2003.
    Shoenfeld Y; Toubi E; Hiepe F
    Autoimmun Rev; 2004 Feb; 3(2):77-84. PubMed ID: 15003191
    [No Abstract]   [Full Text] [Related]  

  • 38. Generation of humanized anti-DNA hydrolyzing catalytic antibodies by complementarity determining region grafting.
    Kim DS; Lee SH; Kim JS; Lee SC; Kwon MH; Kim YS
    Biochem Biophys Res Commun; 2009 Feb; 379(2):314-8. PubMed ID: 19103171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human antibodies in cancer and autoimmune disease.
    Ditzel HJ
    Immunol Res; 2000; 21(2-3):185-93. PubMed ID: 10852116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apoptosis and autoimmunity.
    Navratil JS; Liu CC; Ahearn JM
    Immunol Res; 2006; 36(1-3):3-12. PubMed ID: 17337761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.